Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5219)
All Articles published online
|
Publishing Process of This Article
|
Apr 10, 2017 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Fazio N. Watch and wait policy in advanced neuroendocrine tumors: What does it mean? World J Clin Oncol 2017; 8(2): 96-99 [PMID: 28439490 DOI: 10.5306/wjco.v8.i2.96] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v8/i2/96.htm |
| Number | Citing Articles |
| 1 |
Jingjing Zhang, Qingxing Liu, Aviral Singh, Christiane Schuchardt, Harshad R. Kulkarni, Richard P. Baum. Prognostic Value of 18F-FDG PET/CT in a Large Cohort of Patients with Advanced Metastatic Neuroendocrine Neoplasms Treated with Peptide Receptor Radionuclide Therapy. Journal of Nuclear Medicine 2020; 61(11): 1560 doi: 10.2967/jnumed.119.241414
|
| 2 |
Mirco Bartolomei, Alfredo Berruti, Massimo Falconi, Nicola Fazio, Diego Ferone, Secondo Lastoria, Giovanni Pappagallo, Ettore Seregni, Annibale Versari. Clinical Management of Neuroendocrine Neoplasms in Clinical Practice: A Formal Consensus Exercise. Cancers 2022; 14(10): 2501 doi: 10.3390/cancers14102501
|
| 3 |
Jaume Capdevila, Jorge Hernando, Santiago Perez-Hoyos, Alejandro Roman-Gonzalez, Enrique Grande. Meta-Analysis of Randomized Clinical Trials Comparing Active Treatment with Placebo in Metastatic Neuroendocrine Tumors. The Oncologist 2019; 24(12): e1315 doi: 10.1634/theoncologist.2018-0675
|